LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2021

Jan 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2021-01-11

Reporting Person: OBUS NELSON (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-11	Common Stock	P	6400	$10.81	Acquired	2891700	Indirect
2021-01-12	Common Stock	P	13600	$10.74	Acquired	2905300	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36115	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.75 to $10.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or
the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.65 to $10.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or
the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.